GINA MELE: Open Payments
NPI 1467772780 · GREEN COVE SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 23 payments from 10 companies in 2025. Trend: 2023 $1,077 · 2024 $543 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Kerendia, NEFFY, TZIELD, EVENITY, FARXIGA, GARDASIL 9, QULIPTA.
Industry payments across FL — which companies pay providers there.
